Evaluation of the Bactec serum gentamicin assay.

Antimicrobial Agents and Chemotherapy
J P Manos, P F Jacobs

Abstract

A radiometric assay for gentamicin was compared with an established radioimmunoassay protocol. The coefficients of variation for within-run, day-to-day, and overall runs were consistently higher for the radiometric method as compared with the radioimmunoassay. The coefficient of correlation for 84 patient sera tested by the two methods for gentamicin levels was 0.82. Though less precise, the radiometric method was felt to be an acceptable means of determining gentamicin levels in laboratories where the radioimmunoassay is unavailable.

References

Nov 1, 1976·Antimicrobial Agents and Chemotherapy·S M JonesH H Balfour
Jan 1, 1975·Antimicrobial Agents and Chemotherapy·B H MinshewC R Baxter
Jun 1, 1974·American Journal of Clinical Pathology·K Brooks, T Sodeman
Oct 18, 1972·Nature: New Biology·J E LewisH A Elder
Mar 16, 1972·The New England Journal of Medicine·D H SmithA L Smith
Jun 1, 1973·Applied Microbiology·S M LarsonH N Wagner
May 1, 1974·The Journal of Infectious Diseases·R K Holmes, J P Sanford
Nov 1, 1973·Antimicrobial Agents and Chemotherapy·M E LundJ M Matsen
May 1, 1973·Antimicrobial Agents and Chemotherapy·D V Alcid, S J Seligman
Oct 1, 1973·Antimicrobial Agents and Chemotherapy·M J Haas, J Davies
May 1, 1973·Antimicrobial Agents and Chemotherapy·W A MahonT W Wilson
Nov 1, 1971·Applied Microbiology·H J DeBlancH N Wagner
Dec 1, 1971·The Journal of Infectious Diseases·L J Riff, G G Jackson

❮ Previous
Next ❯

Citations

Apr 1, 1981·Antimicrobial Agents and Chemotherapy·L E PhillipsT E Rogers

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.